Seroquel XL - not enough

When an antidepressant is not enough, add Seroquel XL.

Seroquel XL is now licensed as add-on treatment for patients with major depressive disorder (MDD) who have had suboptimal response to antidepressant monotherapy. Prior to initiating treatment, clinicians should consider the safety profile of Seroquel XL.

Brand name: Seroquel XL
Generic name/category: quetiapine prolonged release
Company: AstraZeneca
Country/Market: UK, Europe
Indication(s)/Category: Major Depression Disorder (MDD)
Target: Healthcare Professionals (HCP)
Tagline: none
Medium: Print ad
Size/duration: Double-page spread
Publication/Aired: The British Journal Of Clinical Pharmacy - December 2010

To see more of this brand's ads, click here


Album name:	Admin / Throwback Thursday
Keywords:	_Seroquel_brand / 2010_publication_year / Seroquel_XL / Seroquel / quetiapine_prolonged_release / Mental_illness / Psychiatry / Psychology / Branded / AstraZeneca / UK / Europe / HCP / Prescription / double-page_spread / print_ad / English / Major_Depression_Disorder / MDD / Lots_Balancing_Copy / healthcare_category / hcpUK / Blue_color / Blue+color / Blue+color / pink_color / illustration / clean_layout / Pessimistic_message / Published / camera / bedroom / depressed / bag / despair / bed / pillow / sheets / sitting / floor / hand / hands / toilet_paper more
Filesize:	3963 KiB
Date added:	Dec 11, 2010
My Collection:	Add to my collections
Dimensions:	2813 x 2000 pixels
URL:	https://adpharm.net/displayimage.php?pid=22940